Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Depreciation & Amortization - Total (2017 - 2025)

Selectis Health's Depreciation & Amortization - Total history spans 11 years, with the latest figure at $364699.0 for Q3 2025.

  • For Q3 2025, Depreciation & Amortization - Total fell 2.52% year-over-year to $364699.0; the TTM value through Sep 2025 reached $1.1 million, down 33.43%, while the annual FY2023 figure was $1.7 million, 7.06% down from the prior year.
  • Depreciation & Amortization - Total for Q3 2025 was $364699.0 at Selectis Health, up from $362742.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $1.7 million in Q1 2021 and bottomed at -$447070.0 in Q3 2021.
  • The 5-year median for Depreciation & Amortization - Total is $430754.0 (2023), against an average of $440593.9.
  • The largest YoY upside for Depreciation & Amortization - Total was 366.0% in 2021 against a maximum downside of 215.29% in 2021.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then decreased by 13.15% to $374118.0 in 2024, then dropped by 2.52% to $364699.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Depreciation & Amortization - Total are $364699.0 (Q3 2025), $362742.0 (Q2 2025), and $363020.0 (Q1 2025).